Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

NEXGEL Highlights Publication Of Study Evaluating SilverSeal In SAGE Journals’ Scars, Burns And Healing

NEXGEL, Inc. (NASDAQ:NXGL, NXGLW)))), ("NEXGEL" or the "Company"), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced
byBenzinga Newsdesk
October 3, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

NEXGEL, Inc. (NASDAQ:NXGL, NXGLW))))), (“NEXGEL” or the “Company”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced today that SAGE Journals’ Scars, Burns and Healing publication, a peer-reviewed journal that focuses on scar and burns research, has published new data from a study evaluating the impact of NEXGEL’s SilverSeal® hydrogel dressing on postoperative scarring and complications. The results demonstrated significant scar improvement in patients treated with SilverSeal.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Design Therapeutics To Present Preclinical Data Highlighting The Potential Of Its GeneTAC Small Molecule, DT-216, For The Treatment Of Friedreich Ataxia At International Congress for Ataxia Research 2022 November 3

By Benzinga Newsdesk
Today, 5:29 AM
Design Therapeutics, Inc. (NASDAQ:DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that preclinical data for the company's novel

DSGN